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 Abstract 
  Background:   Subcortical ischemic vascular dementia (SIVD) has been proposed as the most 
frequent subtype of vascular cognitive impairment. The aim of this study was to evaluate the 
psychometric properties of the Chinese (Cantonese) Montreal Cognitive Assessment (CC-
MoCA) in patients with SIVD in the Guangdong Province of China.   Methods:   71 SIVD patients 
and 60 matched controls were recruited for the CC-MoCA, Mini Mental State Examination and 
executive clock drawing tasks. Receiver-operating characteristic curve analyses were performed 
to determine optimal sensitivity and specificity of the CC-MoCA total score in differentiating 
mild vascular dementia (VaD) patients from moderate VaD patients and controls.   Results:   The 
mean CC-MoCA scores of the controls, and mild and moderate VaD patients were 25.2   8   3.8, 
16.4   8   3.7, and 10.0   8   5.1, respectively. In our study, the optimal cutoff value for the CC-MoCA 
to be able to differentiate patients with mild VaD from controls is 21/22, and 13/14 to differenti-
ate mild VaD from moderate VaD.   Conclusion:   The CC-MoCA is a useful cognitive screening in-
strument in SIVD patients.    Copyright © 2011 S. Karger AG, Basel 
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 Introduction 
  Subcortical ischemic vascular dementia (SIVD) has been proposed as the most frequent 
subtype of vascular cognitive impairment (VCI)   [1]  . The syndrome is defined clinically by 
cognitive impairment and evidence of subcortical vascular brain injury, including lacunar in-
farcts and deep white matter changes. SIVD has been traditionally recognized as lacunar state, 
strategic infarct dementia and Binswanger syndrome   [2]  . Executive dysfunction, which is 
characterized by decreasing mental processing speed, decreased working memory, and im-
paired abstract reasoning, is a recognized feature of VCI. Cognitive tests can usefully differ-
entiate between vascular dementia (VaD) and Alzheimer’s disease (AD), but standard cogni-
tive assessments, such as the Mini Mental State Examination (MMSE)   [3]  , are insensitive to 
detect patients with mild symptoms and non-Alzheimer’s type cognitive impairment such as 
VCI  [4] . Recently, the Montreal Cognitive Assessment (MoCA)  [5]  has been developed in view 
of the inadequacies of the MMSE. It is recommended by the National Institute of Neurological 
Disorders and Stroke-Canadian Stroke Network VCI Harmonization Standard as a brief cog-
nitive tool for the early detection of VCI   [6]  . Unlike the MMSE, the MoCA includes addition-
al memory items and emphasizes attentional/executive and language tasks. The validity of the 
MoCA has been studied in various clinical groups   [7–11]  . Using a cutoff score   ^  26, the sensi-
tivity of the MoCA for identifying mild cognitive impairment (MCI) and AD was excellent (90 
and 100%, respectively). Specificity for correctly classifying cognitively normal individuals 
was also very high (87%)   [5]  . A follow-up study using a prospective design conducted in the 
UK found similarly high sensitivities of 83 and 94%, respectively, for MCI and dementia of any 
kind. Specificity however was modest (50%)   [12]  . Recently, using a translated version of the 
MoCA in a study conducted in Korea, Lee et al.   [13]   reported high sensitivities for the detec-
tion of MCI using lower cutoff scores of 22/23. Most of these studies only examined the abil-
ity of the MoCA to differentiate between diagnostic groups (i.e. criterion validity) but did not 
reflect the degree of cognitive injury in VCI. Moreover, in patients with mild-to-moderate 
VaD, the score area and cutoff value of the MoCA has not been reported. The current study 
intended to investigate the score area of the Chinese (Cantonese) MoCA (CC-MoCA) in SIVD 
patients and cognitively normal healthy controls in the Guangdong Province of China.
  Patients  and  Methods 
 Subjects 
  Patients were recruited from the Stroke Center of the Second Affiliated Hospital of the 
Guangzhou University of Traditional Chinese Medicine. The inclusion criteria were (1) a di-
agnosis of possible or probable VaD lasting   1  3 months, as defined by NINDS-AIREN crite-
ria; (2) MRI evidence of significant SIVD, which is defined as the presence of lacunar state, 
strategic infarct, and confluent white matter lesions (WMLs); (3) mild and moderate demen-
tia [global score of 1 and 2 by Clinical Dementia Rating (CDR), respectively]   [14]  ; (4) an 
MMSE score between 10 and 26, and (5) ability to perform cognitive and motor tasks for 
neuropsychological assessment. Patients with significant depression or other psychiatric dis-
orders assessed by the 4th edition of the Diagnostic and Statistical Manual of Mental Disor-
ders   [15]   and MRI evidence of cortical infarct or a history of hemorrhagic stroke were ex-
cluded. Controls were relatives of the study patients, staff or volunteers recruited from the 
hospital or nearby community centers. Inclusion criteria for controls were (1) normal cogni-
tion defined by a CDR of 0 and MMSE   6  26 and (2) absence of a history of stroke. Subjects 
were also excluded from participating as a control if they had evidence of significant small 
vascular disease on MRI or cognitive complaints. Common exclusion criteria for all subjects 278
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were (1) presence of coexisting medical conditions potentially affecting cognition (e.g. vita-
min B  12   deficiency, hypothyroidism, chronic alcoholism, and active psychiatric disorders); 
(2) other conditions that might affect testing (e.g. severe aphasia, visual or hearing impair-
ment), and (3) contraindication to MRI. All subjects were of Chinese ethnicity and spoke 
Cantonese as their primary language. The study was approved by the Clinical Research Eth-
ics Committee of the Guangzhou University of Traditional Chinese Medicine, and written 
informed consent was given by each participant.
  MRI  Examination 
  MRI was performed on all subjects using a 1.5-tesla scanner (Sonata; Siemens Medical 
Systems, Erlangen, Germany). WMLs were determined as ill-defined hyperintensities with a 
diameter  6  5 mm on T  2   and fluid-attenuated inversion recovery sequences. A neurologist and 
a trained scientist visually assessed the severity of WMLs on these sequences, graded WMLs 
in 5 areas (frontal, parietal-occipital, temporal, infratentorial, and basal ganglia) using the scale 
of Wahlund et al.   [16]   and further grouped the lesions as nonconfluent (grades 0–2) or conflu-
ent (grade 3). Significant SIVD is defined as the presence of a confluent lesion in   6 1  area.
  Scale  Assessment 
  The MMSE, CC-MoCA and executive clock drawing task (CLOX) tests were adminis-
tered approximately 3 months after discharge to the stroke patients. The Chinese MMSE  [17]  
was used to index general cognition. The CC-MoCA form and administration instructions 
are available for download at the MoCA official website (http://www.mocatest.org). Scores 
of the MMSE and MoCA range from 0 to 30. The CLOX has been divided into two parts to 
help discriminate the executive control of clock drawing from clock drawing itself   [18]  . The 
patient is first instructed to draw a clock on the back of the CLOX form. The instructions 
can be repeated until they are clearly understood, but once the subject begins to draw no 
further assistance is allowed. The subject’s performance is rated according to the CLOX di-
rections, and scored as ‘CLOX1’. The second step of CLOX is a simple copying task. The ex-
aminer allows the patient to observe him or her drawing a clock in the circle provided on the 
scoring sheet. The patient is allowed to copy the examiner’s clock. This clock is scored as 
‘CLOX2’. Scores of the CLOX1 and CLOX2 range from 0 to 15. 
  A n a l y s e s  
  All statistical procedures were performed with SPSS 15.0 for Windows (SPSS Inc., Chi-
cago, Ill., USA). Demographic and neuropsychological data are compared between controls 
and patients using an independent t test or the     2   test, as appropriate. The MMSE, CC-
MoCA, CLOX1 and CLOX2 scores were compared with age, gender, and education adjusted 
using analysis of covariance.
    We examined the ability of the CC-MoCA total score in differentiating mild VaD pa-
tients from controls and moderate VaD patients using a receiver operating curve (ROC) 
analysis. We then derived a cutoff score at the optimal balance of sensitivity and specificity.
  R e s u l t s  
 Subject  Characteristics 
 Seventy patients and 61 controls were recruited. Thirty (n = 30, 43%) of the patients were 
rated as having mild dementia (CDR 1), while the remainder (n = 40, 57%) was rated as hav-
ing moderate dementia (CDR 2). The mean age and duration of education for the total sam-
ple were 70.1 (SD = 7.88) and 8.84 years (SD = 3.20), respectively. Demographic information, 279
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and MMSE, MoCA and CLOX scores for the three groups are shown in   table 1  . No differ-
ences were found among groups regarding age (F = 1.697, p = 0.187) and gender (    2   = 5.442, 
p = 0.066). The educational level of patients with moderate VaD was lower than that of pa-
tients with mild VaD (p = 0.004) and controls (p = 0.007).
    Group Differences and ROC Analysis of MoCA, CLOX and MMSE Performance 
  The mean MMSE and MoCA scores of the controls were 28.3   8   1.5 and 25.2   8   3.8, re-
spectively. Although normal MMSE scores (  6  26) were part of the eligibility criteria, 45.3% 
of the normal controls met the criteria for cognitive impairment based on their MoCA score 
( !  26). In controls, CLOX1 and CLOX2 scores were 12.4  8   1.49 and 13.8  8   1.2, respectively, 
in accord with previous reports. The average administration time for the MoCA was   ! 15 
min. The order of administration did not affect test performance. MMSE, MoCA, CLOX1 
and CLOX2 scores were gradually decreasing from controls to mild and moderate VaD pa-
tients, as expected (  table 1  ). 
    ROC analyses for mild VaD versus controls, and mild versus moderate VaD are shown 
in   table 2  . In control and mild dementia groups, a cutoff score   ^  21.5 on the MoCA resulted 
in excellent sensitivity (86.8%) and specificity (92.9%) for detecting mild VaD (area under the 
curve, AUC = 0.934;   fig. 1  ). In the patients with mild or moderate VaD, a score   ^ 13.5  was 
optimal for the MoCA to detect moderate dementia, with a sensitivity of 81.0% and specific-
ity of 85.7% (AUC = 0.857).
  Discussion 
  Brief screening instruments provide an objective and cost-effective means of determin-
ing the need for further evaluation of cognitive problems for older individuals at risk for de-
mentia, if they are easy to administer, score, and interpret, and have acceptable ability to 
identify dementia or MCI   [10]  . This study provides data showing that the CC-MoCA, a 
30-point scale including memory, attention, and executive and language tasks, is effective in 
differentiating SIVD patients from non-stroke, normal-cognition controls, and has also 
demonstrated good concurrent validity, as shown by the significant correlations with the 
MMSE and CLOX test. Consistent with previous reports, we found that performance on the 
CC-MoCA is affected by education   [19–21]  , but not by age or gender. As stated by Lee et al. 
Table 1. D  emographic data and clinical features of the study subjects 
Controls
(n = 61)
Mild VaD
(n = 30)
Moderate VaD
(n = 40)
p value
Age, years 68.887.4 70.188.4 71.788.1 0.187
Education, years 9.383.3 9.783.2 7.582.5a 0.005
Females, % 67.4 46.2 64.4 0.066
MMSE 28.381.5b 22.281.4b 15.482.9b <0.001
MoCA 25.283.8b 16.483.7b 10.085.1b <0.001
CLOX1 12.481.49b 8.983.4b 5.884.1b <0.001
CLOX2 13.881.2b 12.182.4b 8.683.9b <0.001
M eans  (crude)  8 SD.
a Moderate VaD < mild VaD and controls (p = 0.005). 
b Moderate VaD < mild VaD < controls (p < 0.001).280
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 [13]  and Wong et al.  [19] , in many Asian countries, elderly received much less education than 
their counterparts in Western countries. The average education level of our Chinese sample 
is 7–10 years, which is lower than the 12 years of education reported in Caucasian studies  [5] . 
An education cutoff at 12 years, as proposed in the original MoCA study, is therefore not 
useful given that only 16% of our subjects were above this cutoff. 
  For all subjects, the scores on the CC-MoCA were significantly lower than the scores for 
the MMSE. Memory testing using the MoCA involves more words and a longer delay than 
in the MMSE. In contrast to the MMSE, the MoCA also assesses domains affected early in 
VaD patients, e.g. executive and visuospatial functions. ROC analysis suggested that CC-
MoCA provided both excellent sensitivity and specificity for discriminating mild VaD pa-
Table 2.   ROC analyses for mild VaD versus controls, and mild versus moderate VaD
Test parameter AUC Cutoff Sensitivity Specificity
Mild VaD vs. controls 
MMSE 0.991 26.5 0.918 1.000
MoCA 0.934 21.5 0.868 0.929
CLOX1 0.831 11.5 0.912 0.633
CLOX2 0.756 12.5 0.825 0.633
Mild vs. moderate VaD
MMSE 1.000 20.5 0.933 1.000
MoCA 0.857 13.5 0.810 0.857
CLOX1 0.721 7.5 0.700 0.559
CLOX2 0.793 10.5 0.867 0.636
R elationship between scales: the scores of MoCA correlated significantly with that of MMSE (r = 0.886, 
p < 0.001), CLOX1 (r = 0.673, p < 0.001) and CLOX2 (r = 0.613, p < 0.001) in all subjects.
  Fig. 1.   ROC curve depicting the 
ability of the CC-MoCA in dif-
ferentiating patients with mild 
SIVD from controls. AUC = 
0.934, p   !   0.001. 281
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tients from healthy controls at a cutoff value 21/22, and for discriminating moderate from 
mild VaD patients at a cutoff value 13/14. However, we also found that the MMSE gave high-
er values of AUC, sensitivity and specificity than CC-MoCA. However, since the MoCA was 
primarily developed and validated to detect VCI in particular, there may be a floor effect in 
mild/moderate VaD patients.
    The correlation between the MMSE and the CC-MoCA was moderately high, in agree-
ment with other studies   [9, 10, 19]  . The CLOX test was selected to help discriminate the ex-
ecutive control of clock drawing from clock drawing itself. The difference between CLOX1 
and CLOX2 is hypothesized to reflect the specific contribution of executive control versus 
visuospatial tasks to overall clock drawing performance assessed by CLOX1   [18]  . The rela-
tively higher scores in CLOX2 than CLOX1 in our VaD patients were reflective of the prom-
inent executive function impairments in SIVD.
    There are several limitations of this study. First, we used a limited cognitive testing bat-
tery. Second, we only examined the ability of the CC-MoCA to differentiate between VaD 
patients and controls, rather than between patients with VCI with and without dementia. 
Unfortunately, the small sample size does not allow further stratification of patients into 
cognitive subgroups. Future studies including a larger sample size should be designed for this 
purpose, and patients with VCI without dementia should be recruited. Last, in our study, 
some SIVD patients possibly had concurrent AD, because the clinical diagnosis is not the 
gold standard. In future studies, analysis of the concentrations of three protein biomarkers 
in cerebrospinal fluid (amyloid     1–42  , total tau and phosphorylated tau) is required to indi-
cate the presence of AD. 
    In conclusion, the CC-MoCA is a psychometrically valid, reliable and clinically useful 
screening test for patients with SIVD.
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